BNET Industries
Hospira Inc. (HSP) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $3.4B
- Profit
- Dec 31 2007
- $136.7M
- Market Cap
- Aug 27 2008
- $6.2B
Latest News and Analysis
Hospira, Inc. Q2 2008 Earnings Call Transcript
Hospira, Inc. HSP Q2 FY08 Earnings Call
Hospira, Inc. Q1 2008 Earnings Call Transcript
Hospira, Inc. Q1 2008 Earnings Call Transcript
Hospira, Inc. Q4 2007 Earnings Call Transcript
Hospira, Inc. Q4 2007 Earnings Call Transcript
InnerWireless Announces Technology Integration Partnerships with Cisco, Hospira and PatientKeeper
Converged wireless solutions enhance clinical mobility, workflow and outcomes;
Hospira Q3 2007 Earnings Call Transcript
Hospira Q3 2007 Earnings Call Transcript
Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval.
LAKE FOREST, Illinois, October 19 /PRNewswire/ -- LAKE FOREST, Illinois, October 19 /PRNewswire/ --
Minnetronix Announces Hospira Symbiq™ Infusion System Wins Gold Medical Design Excellence Award
Minnetronix Cited for Role as Supplier
The Recent Hospira Generics Company Intelligence Report Identifies if the Company is Applying for ANDAs and Evaluates its Competitive Operating Environment
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c44212) has announced the addition of "Hospira Generics Company Intelligence Report" from Espicom Business Intelligence to their offering.
Hospira Symbiq™ Wins Medical Design Excellence Award - Design Concepts cited for role as supplier
MADISON, Wis. -- Design Concepts, Inc. announced today that the Hospira, Inc., Symbiq[TM] Infusion System has received a 2007 Medical Design Excellence Award. Design Concepts, a product development and design consultancy, provided the essential mechanical engineering and industrial design for the award-winning product and was cited for its role as...
Alexander Haig's Health Journal Television Series Featuring Hospira, Pharmacists Mutual & EXP Pharmaceuticals is Streaming
BOCA RATON, Fla. -- Multi-Media Productions USA, Inc. announces that Health Journal Television Series hosted by General Alexander Haig is currently available on the Health Journal Television website: http://www.healthjournaltv.com.
Hospira Worldwide, Inc. to be Featured on Alexander Haig's Health Journal Television Series, March 6, 2007 on Bravo
BOCA RATON, Fla. -- Multi-Media Productions USA, Inc. announces that Hospira Worldwide, Inc. will be featured on Health Journal Television, hosted by General Alexander Haig.
The Chicago M&A show; The Chicago M&A market saw a little bit of everything last year. Here's a roundup of who bought who in 2006, and what it all means.(Focus: Largest Deals of 2006)(Blackstone Group L.P. acquired Equity Office Properties Trust)(
Byline: Michelle Evans 1 Sam Zell sells A PRIVATE-EQUITY BLOWOUT In the blockbuster buyout of the year, Sam Zell agreed to sell his office-building empire to Blackstone Group, a private-equity firm that has been snapping up publicly traded re...
Zacks Broker Upgrades: NCR Corporation, Hospira, Norfolk Southern and Anheuser-Busch
CHICAGO -- Studies have shown that broker upgrades lead to short-term outperformance. Stocks recently upgraded by brokerage analysts include NCR Corporation (NYSE:NCR), Hospira Inc. (NYSE:HSP), Norfolk Southern Corporation (NYSE:NSC) and Anheuser-Busch Cos. Inc. (NYSE:BUD). To learn more about how you can profit from broker upgrades, visit: http://at.zacks.com/?id=139.
Mayne Pharma shareholders back Hospira's $A2.6bn takeover.
Byline: Nabila Ahmed Byline: Nabila Ahmed
Hospira's bid wins Mayne Pharma.
Byline: Nabila Ahmed Byline: Nabila Ahmed
Mayne investors favour Hospira's bid.
Byline: Teresa Ooi Byline: Teresa Ooi
Hospira, STADA and BIOCEUTICALS Enter Into Agreements for Erythropoietin.
LAKE FOREST, Illinois, November 20 /PRNewswire/ -- LAKE FOREST, Illinois, November 20 /PRNewswire/ --
Research and Markets: In September 2006, Hospira Announced a Friendly US$2 Billion Takeover of Mayne Pharma, an Australian Generic Injectable Specialist
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c44212) has announced the addition of Hospira Generics Company Intelligence Report from Espicom Business Intelligence to their offering.
Diagnosis: green and lean: Hospira CEO Chris Begley says manufacturers should become more environmentally responsible. What's more, he's doing something about it.(3 QUICK QUESTIONS)(Interview)
Hospira Inc., a maker of pharmaceutical and medication delivery products, takes lean manufacturing both seriously and literally. Not only is the company dedicated to eliminating waste in all areas of production, but also it is attempting to reduce th Hospira Inc., a maker of pharmaceutical and...
HOSPIRA MISSING THE MARK; Hospital supply firm struggles after ties cut with Abbott Labs.
Byline: MIKE COLIAS Two years after its spinoff from Abbott Laboratories, hospital supply company Hospira Inc. is having trouble hitting its target without its longtime partner. Abbott stopped selling Hospira's products overseas in April after Byline: MIKE COLIAS ...
- Next »
- page 1 of 3
- « Previous
Sort byClose
View by Content TypeClose
- Incorporated: 2003
- CEO: Mr. Christopher B. Begley
Hospira is a global specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care in the acute care setting. Co. is engaged in the development, manufacture and marketing of specialty injectable pharmaceuticals and medication delivery systems that deliver drugs and intravenous fluids. Co. provides contract manufacturing services to pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. Co.'s products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
Key Competitors
Hospira Inc. Company Info
Board of Directors
Mr. Christopher B. Begley
Chairman
Miss Barbara L. Bowles
Mr. Irving W. Bailey II
Lead Director
Mr. Ronald A. Matricaria
Dr. Jacque J. Sokolov M.D.
Mr. Roger W. Hale
Mr. John C. Staley
Dr. Connie R. Curran Ed.D.
Dr. Mark F. Wheeler M.D.
Contact Information
275 North Field Drive
Lake Forest, IL
224 212-2000
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
